Patents by Inventor Peter Ernest Soden

Peter Ernest Soden has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODIES AGAINST AMYLOID-BETA PEPTIDE
    Publication number: 20160024197
    Abstract: Antibodies that bind human ?-amyloid peptide, methods of treating diseases or disorders characterised by elevated ?-amyloid levels or ?-amyloid deposits with said antibodies, pharmaceutical compositions comprising said antibodies and methods of manufacture.
    Type: Application
    Filed: October 13, 2015
    Publication date: January 28, 2016
    Inventors: Stephen Anthony BURBIDGE, Umesh Kumar, Karen Louise Philpott, Peter Ernest Soden, Jonathan Henry Ellis, Susannah K Ford, Volker Germaschewski
  • Antibodies
    Patent number: 9193784
    Abstract: Antibodies that bind human ?-amyloid peptide, methods of treating diseases or disorders characterized by elevated ?-amyloid levels or ?-amyloid deposits with said antibodies, pharmaceutical compositions comprising said antibodies and methods of manufacture.
    Type: Grant
    Filed: June 8, 2012
    Date of Patent: November 24, 2015
    Assignee: Glaxo Group Limited
    Inventors: Stephen Anthony Burbidge, Jonathan Henry Ellis, Susannah K Ford, Volker Germaschewski, Umesh Kumar, Karen Louise Philpott, Peter Ernest Soden
  • Humanized anti-beta-amyloid antibodies
    Patent number: 8921523
    Abstract: Antigen binding proteins that bind ?-amyloid peptide, in particular human ?-amyloid peptide; methods of treating diseases or disorders characterized by elevated ?-amyloid levels or ?-amyloid deposits, particularly Alzheimer's disease and diseases or disorders affecting the eye or optic nerve characterized by elevated ?-amyloid levels or ?-amyloid deposits, including age related macular degeneration and glaucoma type diseases and ?-amyloid dependent cataract formation, with the antigen binding proteins; pharmaceutical compositions comprising the antigen binding proteins; and methods of manufacture.
    Type: Grant
    Filed: December 9, 2008
    Date of Patent: December 30, 2014
    Assignee: Glaxo Group Limited
    Inventors: Philippe Marc Louis Alard, Ian Richard Catchpole, Jonathan Henry Ellis, Susannah Karen Ford, Volker Germaschewski, Gerald Wayne Gough, Alan Peter Lewis, Peter Ernest Soden, Pamela Joan Thomas, Trevor Anthony Kenneth Wattam
  • Antigen binding proteins
    Patent number: 8858943
    Abstract: The present invention relates to methods of treating diseases or disorders affecting the eye or optic nerve characterized by elevated ?-amyloid levels or ?-amyloid deposits, particularly age related macular degeneration and glaucoma type diseases and ?-amyloid dependent cataract formation, with antigen binding proteins that bind ?-amyloid peptide and in particular human ?-amyloid peptide.
    Type: Grant
    Filed: September 23, 2008
    Date of Patent: October 14, 2014
    Assignee: Glaxo Group Limited
    Inventors: Stephen Anthony Burbidge, Ian Richard Catchpole, Jonathan Henry Ellis, Susannah Karen Ford, Volker Germaschewski, Umesh Kumar, Karen Louise Philpott, Peter Ernest Soden
  • ANTIBODIES
    Publication number: 20140050719
    Abstract: Antibodies that bind human ?-amyloid peptide, methods of treating diseases or disorders characterised by elevated ?-amyloid levels or ?-amyloid deposits with said antibodies, pharmaceutical compositions comprising said antibodies and methods of manufacture.
    Type: Application
    Filed: June 8, 2012
    Publication date: February 20, 2014
    Inventors: Stephen Anthony Burbidge, Jonathan Henry Ellis, Susannah K. Ford, Volker Germaschewski, Umesh Kumar, Karen Louise Philpott, Peter Ernest Soden
  • Antibodies against amyloid-? peptide
    Patent number: 8227576
    Abstract: Antibodies that bind human ?-amyloid peptide, methods of treating diseases or disorders characterised by elevated ?-amyloid levels or ?-amyloid deposits with said antibodies, pharmaceutical compositions comprising said antibodies and methods of manufacture.
    Type: Grant
    Filed: March 27, 2007
    Date of Patent: July 24, 2012
    Assignee: Glaxo Group Limited
    Inventors: Stephen Anthony Burbidge, Jonathan Henry Ellis, Susannah K Ford, Volker Germaschewski, Umesh Kumar, Karen Louise Philpott, Peter Ernest Soden
  • Antibodies Against Amyloid-Beta Peptide
    Publication number: 20110142824
    Abstract: Antibodies that bind human ?-amyloid peptide, methods of treating diseases or disorders characterised by elevated ?-amyloid levels or ?-amyloid deposits with said antibodies, pharmaceutical compositions comprising said antibodies and methods of manufacture.
    Type: Application
    Filed: March 27, 2007
    Publication date: June 16, 2011
    Applicant: GLAXO GROUP LIMITED
    Inventors: Stephan Anthony Burbidge, Jonathan Henry Ellis, Susannah K Ford, Volker Germaschewski, Umesh Kumar, Karen Louise Phillpott, Peter Ernest Soden
  • ANTIGEN BINDING PROTEINS
    Publication number: 20110064740
    Abstract: The present invention relates to methods of treating diseases or disorders affecting the eye or optic nerve characterised by elevated ?-amyloid levels or ?-amyloid deposits, particularly age related macular degeneration and glaucoma type diseases and ?-amyloid dependent cataract formation, with antigen binding proteins that bind ?-amyloid peptide and in particular human ?-amyloid peptide.
    Type: Application
    Filed: September 23, 2008
    Publication date: March 17, 2011
    Inventors: Stephen Anthony Burbidge, Ian Richard Catchpole, Jonathan Henry Ellis, Susannah Karen Ford, Volker Germaschewski, Umesh Kumar, Karen Louise Philpott, Peter Ernest Soden
  • ANTIGEN BINDING PROTEINS
    Publication number: 20110014182
    Abstract: Antigen binding proteins that bind ?-amyloid peptide, in particular human ?-amyloid peptide; methods of treating diseases or disorders characterised by elevated ?-amyloid levels or ?-amyloid deposits, particularly Alzheimer's disease and diseases or disorders affecting the eye or optic nerve characterised by elevated ?-amyloid levels or ?-amyloid deposits, including age related macular degeneration and glaucoma type diseases and ?-amyloid dependent cataract formation, with said antigen binding proteins; pharmaceutical compositions comprising said antigen binding proteins; and methods of manufacture.
    Type: Application
    Filed: December 9, 2008
    Publication date: January 20, 2011
    Inventors: Philippe Marc Louis Alard, Ian Richard Catchpole, Jonathan Henry Ellis, Susannah Karen Ford, Gerald Wayne Gough, Volker Germaschewski, Alan Peter Lewis, Peter Ernest Soden, Pamela Joan Thomas, Trevor Anthony Kenneth Wattam
  • ANTIGEN BINDING PROTEINS
    Publication number: 20090162358
    Abstract: Antigen binding proteins that bind ?-amyloid peptide, in particular human ?-amyloid peptide; methods of treating diseases or disorders characterised by elevated ?-amyloid levels or ?-amyloid deposits, particularly Alzheimer's disease and diseases or disorders affecting the eye or optic nerve characterised by elevated ?-amyloid levels or ?-amyloid deposits, including age related macular degeneration and glaucoma type diseases and ?-amyloid dependent cataract formation, with said antigen binding proteins; pharmaceutical compositions comprising said antigen binding proteins; and methods of manufacture.
    Type: Application
    Filed: December 9, 2008
    Publication date: June 25, 2009
    Inventors: Philippe Marc Louis Alard, Jonathan Henry Ellis, Susannah Karen Ford, Volker Germaschewski, Alan Peter Lewis, Peter Ernest Soden, Pamela Joan Thomas, Trevor Anthony Kenneth Wattam